Units

Contact

---

Citation

Type

Journal

Publication Date

Issn Electronic

Pages

Brief description/objective

In Switzerland, like in any other country, cancer remains one
of the most important risks for patient mortality. The development
of a better understanding of cancer and the research
for new, improved treatments remains key. Recognizing these
challenges, the Swiss Group for Clinical Cancer Research
(SAKK) was created in 1965 as a non-profit organization to
address those issues and to promote clinical trials in oncology
all over Switzerland. The Working Group on Brain Tumors
has been developed as a branch of the SAKK to specifically
address the issues related to brain tumors.
Over the years, thanks to the work of its previous presidents,
including Roger Stupp and Silvia Hofer, this working
group has become the center-point for Swiss Neurooncology.
The biannual meetings organized by the SAKK
have served as a meeting point where not only oncologists,
but also neurosurgeons, radiation oncologists, neuroradiologists
and neuropathologists can convene, share ideas, and
develop new projects. The missions of the Brain Tumor
Groups centers on providing an exchange platform for specialists
involved in the management of patients with primary
and secondary brain tumors, on providing regular postgraduate
education in neurooncology to ensure the highest
possible level of care for patients and to foster clinical and
translational research.